The Journal of Allergy and Clinical Immunology
Volume 112, Issue 2 , Pages 438-444, August 2003

The −159 C→T polymorphism of CD14 is associated with nonatopic asthma and food allergy☆☆

  • Jessica G. Woo, MHSA

      Affiliations

    • the Division of Epidemiology and Biostatistics, Department of Environmental Health, University of Cincinnati Medical Center Cincinnati, Ohio
  • ,
  • Amal Assa’ad, MD

      Affiliations

    • the Division of Allergy and Immunology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center Cincinnati, Ohio
  • ,
  • Angela B. Heizer, BA

      Affiliations

    • the Division of Allergy and Immunology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center Cincinnati, Ohio
  • ,
  • Jonathan A. Bernstein, MD

      Affiliations

    • the Division of Immunology, Department of Internal Medicine, University of Cincinnati Medical Center. Cincinnati, Ohio
  • ,
  • Gurjit K. Khurana Hershey, MD, PhD

      Affiliations

    • the Division of Allergy and Immunology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center Cincinnati, Ohio

Received 8 January 2003; received in revised form 1 May 2003; accepted 2 May 2003.

Abstract 

Background: CD14, the receptor for LPS, plays an important role in innate immunity. A polymorphism in the promotor for CD14, −159 C→T, has been implicated in atopy. Objective: We explored the relationship of this polymorphism with both atopic and nonatopic asthma, as well as with food allergy. Methods: Patients with asthma and food allergy were recruited along with nonatopic, nonasthmatic control subjects. The −159 C→T polymorphism was genotyped by using the PCR-based RFLP assay. Results: The −159 T allele was more common among patients with nonatopic asthma and food allergy than among control subjects (χ2 = 6.03, P = .01 and χ2 = 4.94; P = .03, respectively). Patients with food allergy had a 4-fold increased odds of having the TT genotype versus carriers of the C allele compared with control subjects (odds ratio [OR] = 3.9, 95% CI = 1.5-10.3), whereas patients with nonatopic asthma had a 3-fold increased odds of having the TT genotype (OR = 3.1 [95% CI = 1.1-9.1]). Controlling for sex differences between groups did not alter this relationship, which remained significant for patients with food allergy (OR = 3.7 [95% CI = 1.4-10.1]) or nonatopic asthma (OR = 2.7 [95% CI = 0.9-8.0]). We performed a stratified analysis, limited to white patients, to reduce population stratification. The relationship with the TT genotype was stronger in white patients with nonatopic asthma (OR = 4.4 [95% CI = 1.3-14.8]) and patients with food allergy (OR = 5.1 [95% CI = 1.6-16.2]), even adjusting for sex differences (OR = 3.9 [95% CI = 1.1-13.5] and OR = 4.6 [95% CI = 1.4-14.8], respectively). Conclusions: The TT genotype of −159 C→T CD14 is associated with nonatopic asthma and food allergy, particularly in white subjects. Thus CD14 is a candidate gene specifically for nonatopic asthma and not for asthma in general. This indicates that atopic and nonatopic asthma might be distinct conditions in their genetic predisposition, despite the fact that they are very similar once they have been established. (J Allergy Clin Immunol 2003;112:438-44.)

Keywords:  Asthma, allergy, genetics, food hypersensitivity, toll receptors, CD14, LPS

Abbreviations:  ATS , American Thoracic Society, OR , Odds ratio, TLR , Toll-like receptor

 

 Supported by NIH R01AI46652-01A1 (Dr Hershey). Dr Woo was supported by a National Institute of Environmental Health Sciences' Molecular Epidemiology in Children's Environmental Health Training Grant, T32-ES 10957.

☆☆ Reprint requests: Gurjit K. Khurana Hershey, MD, PhD, Division of Allergy and Immunology, Children's Hospital Medical Center, 3333 Burnet Ave, Cincinnati, OH 45229.

PII: S0091-6749(03)01601-4

doi:10.1067/mai.2003.1634

The Journal of Allergy and Clinical Immunology
Volume 112, Issue 2 , Pages 438-444, August 2003